已确定与较高的 COVID-19 死亡率相关的基因变异

本文探讨了在医疗保健环境中使用人工智能聊天机器人的潜在好处。它强调了聊天机器人提供 24/7 支持、自动执行重复任务以及为患者提供个性化体验的能力。此外，它还强调了与聊天机器人部署相关的潜在成本节省和改善的患者治疗结果。

Scientists Identify Genetic Variant Linked to Increased Mortality from COVID-19

科学家发现与 COVID-19 死亡率增加相关的基因变异

Researchers have identified a genetic variant that appears to increase the likelihood of severe outcomes from COVID-19, including death. The variant, known as the p.Leu210His variant, is located in a gene that codes for a protein involved in regulating the immune system.

研究人员发现了一种基因变异，它似乎会增加 COVID-19 导致严重后果（包括死亡）的可能性。该变体被称为 p.Leu210His 变体，位于编码参与调节免疫系统的蛋白质的基因中。

A recent study published in the journal Nature Genetics analyzed genetic data from over 2,000 patients with COVID-19. The results showed that individuals with the p.Leu210His variant were more likely to experience severe symptoms, require hospitalization, and succumb to the disease.

最近发表在《自然遗传学》杂志上的一项研究分析了 2000 多名 COVID-19 患者的遗传数据。结果显示，携带 p.Leu210His 变异的个体更有可能出现严重症状、需要住院治疗并死于该疾病。

"This finding suggests that genetic factors may play a role in determining the severity of COVID-19," said Dr. Mark Daly, lead author of the study. "It could also help identify high-risk individuals who may benefit from targeted preventive measures."

该研究的主要作者 Mark Daly 博士说：“这一发现表明遗传因素可能在决定 COVID-19 的严重程度方面发挥作用。” “它还可以帮助识别可能受益于有针对性的预防措施的高风险人群。”

While the p.Leu210His variant remains relatively rare, the discovery highlights the potential importance of genetic testing in understanding and managing COVID-19. Further research is needed to determine the exact mechanisms by which the variant affects disease severity and to develop strategies to mitigate its effects.

虽然 p.Leu210His 变体仍然相对罕见，但这一发现凸显了基因检测在理解和管理 COVID-19 方面的潜在重要性。需要进一步的研究来确定该变异影响疾病严重程度的确切机制，并制定减轻其影响的策略。